SCHEMBL4825402

SCHEMBL4825402

CCCN(CCC)C(=O)c1cc(C)cc(C(=O)N[C@@H](Cc2cc(F)cc(F)c2)[C@@H](O)[C@H](O)COC2CCCCC2)c1

nearest known ligand 0.65

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.65
BACE2 Q9Y5Z0 3/20 0.59
CTSD P07339 2/20 0.58
CTSE P14091 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4829692 0.99 BACE1 (0.66) BACE1BACE2CTSDCTSE
SCHEMBL4822815 0.98 BACE1 (0.65) BACE1BACE2CTSDCTSE
SCHEMBL8354331 0.98 BACE1 (0.65) BACE1BACE2CTSDCTSE
SCHEMBL4827607 0.92 BACE1 (0.63) BACE1BACE2CTSDCTSE
SCHEMBL4829674 0.92 BACE1 (0.56) BACE1BACE2CTSDCTSE
SCHEMBL8357362 0.92 BACE1 (0.63) BACE1BACE2CTSDCTSE
SCHEMBL14541006 0.92 BACE1 (0.65) BACE1BACE2CTSDCTSE
SCHEMBL5193771 0.89 BACE1 (0.64) BACE1BACE2CTSDCTSE
SCHEMBL4827757 0.89 BACE1 (0.66) BACE1BACE2CTSDCTSE
SCHEMBL8354194 0.88 BACE1 (0.65) BACE1BACE2CTSDCTSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388118-B2 Amine 1,2- and 1,3-diol compounds PHAMACIA & UPJOHN COMPANY LLC (US) 2008-06-17 US claimed
EP-1453792-B1 AMINE 1,2- AND 1,3-DIOL COMPOUNDS AND THEIR USE FOR TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARM INC (US) 2007-04-18 EP claimed
US-7388118-B2 Amine 1,2- and 1,3-diol compounds PHAMACIA & UPJOHN COMPANY LLC (US) 2008-06-17 US disclosed
US-7388118-B2 Amine 1,2- and 1,3-diol compounds PHAMACIA & UPJOHN COMPANY LLC (US) 2008-06-17 US disclosed
WO-2003043975-A1 AMINE 1,2- AND 1,3-DIOL COMPOUNDS AND THEIR USE FOR TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2003-05-30 WO disclosed